Efficacy and safety of adjuvant short-course immune checkpoint inhibitors following TACE combined with MWA in patients with BCLC A–B hepatocellular carcinoma: a single-arm, prospective, phase II study protocol
Authors
- Shuai Zhang
- Zhezhu Han
- Yang Fang
- Jiacheng Chen
- Mingyin Zhang
- Xuezhe Piao
Institutions
- Yanbian University Hospital (CN)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1136/bmjopen-2025-111786
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00